| Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia M Breton, A Farret, D Bruttomesso, S Anderson, L Magni, S Patek, ... Diabetes 61 (9), 2230-2237, 2012 | 363 | 2012 |
| 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial J Kropff, S Del Favero, J Place, C Toffanin, R Visentin, M Monaro, ... The lancet Diabetes & endocrinology 3 (12), 939-947, 2015 | 256 | 2015 |
| Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas BP Kovatchev, E Renard, C Cobelli, HC Zisser, P Keith-Hynes, ... Diabetes care 37 (7), 1789-1796, 2014 | 220 | 2014 |
| Modular closed-loop control of diabetes SD Patek, L Magni, E Dassau, C Karvetski, C Toffanin, G De Nicolao, ... IEEE Transactions on Biomedical Engineering 59 (11), 2986-2999, 2012 | 216 | 2012 |
| MPC based artificial pancreas: strategies for individualization and meal compensation P Soru, G De Nicolao, C Toffanin, C Dalla Man, C Cobelli, L Magni, ... Annual Reviews in Control 36 (1), 118-128, 2012 | 146 | 2012 |
| Artificial pancreas: model predictive control design from clinical experience C Toffanin, M Messori, F Di Palma, G De Nicolao, C Cobelli, L Magni Journal of diabetes science and technology 7 (6), 1470-1483, 2013 | 127 | 2013 |
| Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: results of a single-arm 1-month experience compared with a previously … E Renard, A Farret, J Kropff, D Bruttomesso, M Messori, J Place, ... Diabetes Care 39 (7), 1151-1160, 2016 | 124 | 2016 |
| Run-to-Run Tuning of Model Predictive Control for Type 1 Diabetes Subjects: In Silico Trial L Magni, M Forgione, C Toffanin, C Dalla Man, B Kovatchev, ... Journal of diabetes science and technology 3 (5), 1091-1098, 2009 | 123 | 2009 |
| First use of model predictive control in outpatient wearable artificial pancreas S Del Favero, D Bruttomesso, F Di Palma, G Lanzola, R Visentin, A Filippi, ... Diabetes care 37 (5), 1212-1215, 2014 | 119 | 2014 |
| Toward a run-to-run adaptive artificial pancreas: In silico results C Toffanin, R Visentin, M Messori, F Di Palma, L Magni, C Cobelli IEEE Transactions on Biomedical Engineering 65 (3), 479-488, 2017 | 118 | 2017 |
| Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient … YM Luijf, JH DeVries, K Zwinderman, L Leelarathna, M Nodale, ... Diabetes care 36 (12), 3882-3887, 2013 | 115 | 2013 |
| Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive … S Del Favero, J Place, J Kropff, M Messori, P Keith‐Hynes, R Visentin, ... Diabetes, Obesity and Metabolism 17 (5), 468-476, 2015 | 97 | 2015 |
| Model individualization for artificial pancreas M Messori, C Toffanin, S Del Favero, G De Nicolao, C Cobelli, L Magni Computer methods and programs in biomedicine 171, 133-140, 2019 | 75 | 2019 |
| Dynamic insulin on board: incorporation of circadian insulin sensitivity variation C Toffanin, H Zisser, FJ Doyle III, E Dassau Journal of diabetes science and technology 7 (4), 928-940, 2013 | 73 | 2013 |
| Model predictive control with integral action for artificial pancreas GP Incremona, M Messori, C Toffanin, C Cobelli, L Magni Control engineering practice 77, 86-94, 2018 | 68 | 2018 |
| Individually adaptive artificial pancreas in subjects with type 1 diabetes: a one-month proof-of-concept trial in free-living conditions M Messori, J Kropff, S Del Favero, J Place, R Visentin, R Calore, ... Diabetes Technology & Therapeutics 19 (10), 560-571, 2017 | 68 | 2017 |
| In silico trials of an open-source android-based artificial pancreas: a new paradigm to test safety and efficacy of do-it-yourself systems C Toffanin, M Kozak, Z Sumnik, C Cobelli, L Petruzelkova Diabetes technology & therapeutics 22 (2), 112-120, 2020 | 58 | 2020 |
| Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 … H Zisser, E Renard, B Kovatchev, C Cobelli, A Avogaro, R Nimri, L Magni, ... Diabetes Technology & Therapeutics 16 (10), 613-622, 2014 | 54 | 2014 |
| Therapy-driven deep glucose forecasting EM Aiello, G Lisanti, L Magni, M Musci, C Toffanin Engineering Applications of Artificial Intelligence 87, 103255, 2020 | 46 | 2020 |
| International Artificial Pancreas Study Group: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia M Breton, A Farret, D Bruttomesso, S Anderson, L Magni, S Patek, ... Diabetes 61 (9), 2230-7, 2012 | 40 | 2012 |
Magni LaloProfessor of Automatic Control at University of PaviaVerified email at unipv.it
